P

Inventor

SHARIF NAJAM A

US23 patents
⚠️ This page may combine multiple inventors who share the name “SHARIF NAJAM A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALCON MFG LTD

11 patents
US6664286B1Dec 16, 2003

Serotonergic 5ht2 agonists for treating glaucoma

ALCON MFG LTD38 citations92
US6344477B1Feb 5, 2002

Prostaglandin e agonists for treatment of dry eye

ALCON MFG LTD30 citations92
US6492417B1Dec 10, 2002

11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists

ALCON MFG LTD22 citations90
US7060704B2Jun 13, 2006

Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders

ALCON MFG LTD5 citations74
US6960579B1Nov 1, 2005

Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders

ALCON MFG LTD6 citations74
US6500831B1Dec 31, 2002

Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma

ALCON MFG LTD9 citations73
US6649655B2Nov 18, 2003

11β-fluoro 15β-hydroxy PGF2α analogs as FP receptor antagonists

ALCON MFG LTD11 citations71
US6441033B1Aug 27, 2002

11β-fluoro 15β-hydroxy PGF2α analogs as FP receptor antagonists

ALCON MFG LTD12 citations71
US7285553B2Oct 23, 2007

Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders

ALCON MFG LTD4 citations63
US6531480B1Mar 11, 2003

Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders

ALCON MFG LTD2 citations62
US6545045B1Apr 8, 2003

Prostaglandin E agonists for treatment of glaucoma

ALCON MFG LTD3 citations61

ALCON RES LTD

3 patents
US7867999B1Jan 11, 2011

Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions

ALCON RES LTD7 citations84
US7807629B1Oct 5, 2010

Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma

ALCON RES LTD4 citations62
US7655662B2Feb 2, 2010

(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure

ALCON RES LTD2 citations62

NOVARTIS AG

2 patents
US9604949B2Mar 28, 2017

Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension

NOVARTIS AG5 citations72
US10016441B2Jul 10, 2018

Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension

NOVARTIS AG0 citations51

SHARIF NAJAM A

2 patents
US8263555B2Sep 11, 2012

Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma

SHARIF NAJAM A2 citations58
US8173668B1May 8, 2012

Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma

SHARIF NAJAM A0 citations48

ALCON INC

2 patents
US7718697B2May 18, 2010

Method for treating glaucoma comprising administering α-lipoic acid

ALCON INC3 citations54
US7235556B2Jun 26, 2007

Methods of treating dry eye disorders

ALCON INC0 citations52

NESTEC SA

1 patent
US6284537B1Sep 4, 2001

Immortalized human corneal epithelial cell line

NESTEC SA9 citations71

SANTEN PHARMACEUTICAL CO LTD

1 patent
US11331311B2May 17, 2022

Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound

SANTEN PHARMACEUTICAL CO LTD0 citations59

COMBRINK KEITH D

1 patent
US8252793B2Aug 28, 2012

Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma

COMBRINK KEITH D0 citations28